BioNTech, OncoC4 Phase 3 study put on partial hold by FDA
BioNTech (NASDAQ:BNTX) and OncoC4 have had a partial clinical hold placed by the FDA on a Phase 3 study for their drug ...
BioNTech shares slip as FDA places partial clinical hold on lung cancer study
BioNTech (NASDAQ:BNTX) shares fell Friday after the company said it had been informed by partner OncoC4 that FDA placed ...
BioNTech and Moderna: A tale of two mRNA developers
Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...
FierceBiotech5h
BioNTech-OncoC4 phase 3 cancer trial under partial hold after varying results reported
The FDA has implemented a partial hold on a phase 3 non-small cell lung cancer trial run by BioNTech and OncoC4 after seeing ...
mRNA licensing agreements surge 800% amid GSK lawsuits
Considering the reasons behind the jump in licensing deal values, Chan added: “Licensing agreement deal values for mRNA-based ...
BioNTech's (NASDAQ:BNTX) investors will be pleased with their massive 749% return over the last five years
While the best companies are hard to find, but they can generate massive returns over long periods. To wit, the BioNTech SE ...
Morgan Stanley Sticks to Its Buy Rating for BioNTech SE (BNTX)
In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a ...
How the rapid development of COVID vaccines prepares us for future pandemics
Since COVID was first reported in December 2019, there have been more than 775 million recorded infections and more than 7 ...
DeepMind and BioNTech build AI lab assistants for scientific research
Google DeepMind and BioNTech are building AI lab assistants to help researchers plan scientific experiments and better ...
Atomi Financial Group Inc. Acquires Shares of 3,406 BioNTech SE (NASDAQ:BNTX)
Atomi Financial Group Inc. bought a new position in shares of BioNTech SE (NASDAQ:BNTX – Free Report) during the 3rd quarter, ...
Truist Financial Corp Has $1.27 Million Stock Position in BioNTech SE (NASDAQ:BNTX)
Truist Financial Corp lowered its position in shares of BioNTech SE (NASDAQ:BNTX – Free Report) by 4.1% in the second quarter ...
Morningstar2d
BioNTech SE ADR BNTX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...